Cytokine Profiles in Children With Obstructive Sleep Apnea
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to compare the cytokine profile of tonsillar and peripheral blood mononuclear cells in patients with obstructive sleep apnea (OSA) and to compare the blood mononuclear cell cytokine secretion profile between patients with obstructive sleep apnea and controls without apnea.
| Condition | Intervention |
|---|---|
|
Obstructive Sleep Apnea Syndrome |
Procedure: tonsillectomy |
| Study Type: | Interventional |
| Study Design: | Intervention Model: Parallel Assignment Masking: Open Label |
| Official Title: | Local and Systemic Cytokine Profiles in Children With Obstructive Sleep Apnea and Controls |
- levels of cytokines released from PBMCs of OAS subjects and controls [ Time Frame: just prior to surgery ] [ Designated as safety issue: No ]
- cytokine level comparison between PBMCs and tonsillar lymphocytes within OAS groups [ Time Frame: at time of surgery ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 40 |
| Study Start Date: | April 2006 |
| Estimated Study Completion Date: | December 2008 |
| Estimated Primary Completion Date: | September 2008 (Final data collection date for primary outcome measure) |
-
Procedure: tonsillectomy
We will recruit subjects with OSA about to undergo adenotonsillectomy and collect a blood sample and portion of their tonsils after the induction of general anesthesia. The mononuclear cells will be isolated from both these tissues and stimulated with different markers and cytokines assayed and compared. We will also recruit patients with no symptoms of OSA undergoing unrelated elective surgery and ascertain the absence of OSA by having the parents fill out a sleep questionnaire. We will then collect blood samples from these patients after the induction of anesthesia and examine the cytokine secretion profile and compare it to that of the children with OSA.
Eligibility| Ages Eligible for Study: | 18 Months to 12 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- OSA documented by polysomnography and clinical symptoms.
- Patients with no symptoms of OSA and negative sleep questionnaire.
Exclusion Criteria:
- Significant systemic disease except mild asthma
Contacts and Locations| Contact: Fuad M Baroody, MD | 773-702-4790 | fbaroody@surgery.bsd.uchicago.edu |
| United States, Illinois | |
| University of Chicago | Recruiting |
| Chicago, Illinois, United States, 60637 | |
| Principal Investigator: Fuad M Baaroody, MD | |
| Principal Investigator: | Fuad M Baroody, MD | University of Chicago |
More Information
No publications provided
| Responsible Party: | Fuad M. Baroody, MD, University ofChicago |
| ClinicalTrials.gov Identifier: | NCT00456573 History of Changes |
| Other Study ID Numbers: | 002 (14437B) |
| Study First Received: | April 3, 2007 |
| Last Updated: | June 2, 2008 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by University of Chicago:
|
Pediatric Obstructive sleep apnea syndrome |
Additional relevant MeSH terms:
|
Apnea Sleep Apnea Syndromes Sleep Apnea, Obstructive Respiration Disorders Respiratory Tract Diseases Signs and Symptoms, Respiratory |
Signs and Symptoms Sleep Disorders, Intrinsic Dyssomnias Sleep Disorders Nervous System Diseases |
ClinicalTrials.gov processed this record on May 19, 2013